2025-12-30 - Analysis Report
Okay, let's break down this report on Northrop Grumman (NOC).

**1. Return Rate Comparison and Alpha/Beta Analysis**

*   **Company Overview:** Northrop Grumman Corp. is a global aerospace and defense technology company.

*   **Return Rate Comparison:**
    *   NOC Cumulative Return: 49.81%
    *   VOO (S&P 500) Cumulative Return: 103.21%
    *   Divergence: -53.4%
    *   Relative Divergence: 5.2%

*   **Analysis:** NOC has significantly underperformed the S&P 500 over the period examined. The divergence of -53.4% means that NOC's return is 53.4 percentage points lower than the S&P 500. The relative divergence of 5.2% suggests that this underperformance is near the minimum range of historical divergence. This implies that, while NOC is underperforming significantly, it is doing so to a degree that is not entirely unprecedented.

*   **Alpha/Beta Analysis Table:**

| Year       | CAGR   | MDD   | Alpha   | Beta  | Cap(B) |
|------------|--------|-------|---------|-------|--------|
| 2015-2017  | 46.0%  | 65.6% | 17.0%   | 0.0   | 44.0   |
| 2016-2018  | -2.0%  | 74.3% | -17.0%  | 0.0   | 35.1   |
| 2017-2019  | 17.0%  | 79.2% | -5.0%   | 0.9   | 49.3   |
| 2018-2020  | -28.0% | 79.9% | -52.0%  | 0.8   | 43.7   |
| 2019-2021  | 43.0%  | 79.9% | -4.0%   | 0.8   | 55.5   |
| 2020-2022  | 18.0%  | 79.9% | 19.0%   | 0.3   | 78.2   |
| 2021-2023  | 24.0%  | 82.7% | 23.0%   | 0.2   | 67.1   |
| 2022-2024  | -15.0% | 82.7% | -36.0%  | 0.2   | 67.2   |
| 2023-2025  | -1.0%  | 82.1% | -68.0%  | 0.1   | 82.7   |

*   **Alpha/Beta Analysis:**
    *   **Alpha:** NOC's alpha is inconsistent, fluctuating significantly. Recent years (2023-2025) show a particularly negative alpha (-68.0%), indicating substantial underperformance relative to its risk profile.
    *   **Beta:** The beta values are generally low (close to 0), indicating that NOC's price is not highly correlated with the overall market (S&P 500). It has been consistently low in recent years (around 0.1~0.2), suggesting NOC is relatively insensitive to broad market movements.
    *   **CAGR & MDD:** CAGR (Compound Annual Growth Rate) fluctuates and the MDD (Maximum Drawdown) remains high across the board, suggesting a potential risk issue.
    *   **Capitalization:** Market Cap has grown from 44B to 82.7B.

**2. Recent Stock Price Fluctuations**

*   **Current Price:** 577.37
*   **Last Market Data:** Price: 577.78, Previous Close: 577.37, Change: 0.07 (A very small increase)
*   **Moving Averages:**
    *   5-day SMA: 578.58
    *   20-day SMA: 563.55
    *   60-day SMA: 580.01

*   **Analysis:**
    *   The 5-day SMA is above the 20-day SMA, which suggests a short-term upward trend.
    *   However, the 60-day SMA is above both the 5-day and 20-day SMAs, suggesting a longer-term downward trend or stabilization.
    *   The last market data reveals a very minor price increase, indicating minimal recent momentum.

**3. RSI, PPO, and Expected Return**

*   **Market Risk Indicator (MRI):** 0.9 (Medium Investment Recommended)
*   **RSI:** 66.52
*   **PPO:** 0.55
*   **Hybrid Signal:** Buy 100% of cash (4 shares - Very Safe - MRI:0.90) Dividend_2.31 Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent Relative Divergence Change:** -0.5 (Short-term Decline)
*   **Expected Return:** -151.2%

*   **Analysis:**
    *   **MRI:** A medium investment recommendation suggests a balance between potential reward and risk.
    *   **RSI:** 66.52 indicates that the stock is approaching overbought territory but is not there yet.
    *   **PPO:** A positive PPO suggests an upward trend, but the value is small.
    *   **Hybrid Signal:** The hybrid signal gives a "Buy" signal.
    *   **Recent Relative Divergence Change:** The negative change indicates recent underperformance compared to the S&P 500.
    *   **Expected Return:** The extremely negative expected return suggests that, based on current analysis, the model predicts significant underperformance in the long term compared to the S&P 500 if invested from the current point.

**4. Recent News & Significant Events**

*   **Government Contract Update:** A $100M payment to Northrop Grumman Systems Corporation. (Positive)
*   **Technical Analysis:** "Why (NOC) Price Action Is Critical for Tactical Trading" - suggests potential short-term trading opportunities based on price movements. (Neutral)
*   **Valuation Argument:** "Northrop Grumman: An Argument For Buying At Undervaluation (Rating Downgrade)" - a contrarian view suggesting the stock may be undervalued despite a rating downgrade. (Potentially Positive)
*   **Value Assessment:** "Northrop Grumman (NOC): Assessing Value After Recent 5% Pullback in Share Price" - indicates a recent price decline and an analysis of its valuation. (Neutral)
*   **Chart Analysis:** "Northrop Grumman Signal 25/12: More Gains Ahead? (Chart)" - suggests potential for further price increases based on chart patterns. (Potentially Positive)
*   **Return Comparison:** "Will NOC stock beat Nasdaq index returns" - Questions the return performance of the stock vs. the broader Nasdaq index. (Negative)

*   **Analysis:** The news is mixed. There's positive news regarding a government contract, but there are also articles focusing on valuation concerns and potential underperformance compared to market indices.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (Mean: 2.04) based on 21 opinions.
*   **Target Price:** Average: $662.68, High: $770.00, Low: $533.00

*   **Analysis:** Analyst consensus is generally positive (Buy rating) and indicates potential upside from the current price ($577.78) based on the average target price. However, there's a wide range in target prices, suggesting some uncertainty among analysts.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue      |
|------------|------|--------------|
| 2025-10-21 | 7.69 | 10.42 B$     |
| 2025-07-22 | 8.17 | 10.35 B$     |
| 2025-04-22 | 3.33 | 9.47 B$      |
| 2024-10-24 | 7.02 | 10.00 B$     |
| 2025-10-21 | 7.02 | 10.00 B$ |

*   **Analysis:**
    *   Revenue has been generally consistent, fluctuating in the 9.47-10.42 Billion range.
    *   EPS has varied, with the highest at 8.17. The EPS in 2025-04-22 was significantly lower than the others.

**6. Financial Information**

*   **Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $10.42B    | 21.37%        |
| 2025-06-30   | $10.35B    | 21.35%        |
| 2025-03-31   | $9.47B     | 16.69%        |
| 2024-12-31   | $10.69B    | 18.08%        |
| 2024-09-30   | $10.00B    | 21.07%        |

*   **Capital and Profitability:**

| Quarter      | Equity     | ROE   |
|--------------|------------|-------|
| 2025-09-30   | $15.99B    | 6.88% |
| 2025-06-30   | $15.47B    | 7.59% |
| 2025-03-31   | $14.98B    | 3.21% |
| 2024-12-31   | $15.29B    | 8.27% |
| 2024-09-30   | $14.75B    | 6.96% |

*   **Analysis:**
    *   Revenue is relatively stable, with some quarterly fluctuations.
    *   Profit margins have been generally high, exceeding 20% in several quarters, but lower in 2025-03-31 and 2024-12-31.
    *   Equity has steadily increased.
    *   ROE fluctuates, with the lowest being in 2025-03-31.

**7. Comprehensive Analysis**

*   **Summary:** NOC has significantly underperformed the S&P 500 recently. Its alpha is inconsistent and recent performance relative to the market has been poor. While analyst consensus suggests a "Buy" rating and potential upside, the technical indicators and expected return paint a less optimistic picture.
*   **Key Considerations:**
    *   **Underperformance:** The substantial underperformance relative to the S&P 500 is a major concern. While the defense sector can sometimes move independently of the broader market, the magnitude of the divergence is noteworthy.
    *   **Mixed Signals:** The "Buy" signal from the hybrid model, and analyst consensus needs to be weighed against the negative expected return and recent relative divergence change.
    *   **Valuation:** Several news articles raise the point of valuation and whether a recent pullback makes the stock attractive.
    *   **Positive Factors:** Government contracts and generally solid revenue and profitability provide some support for the company's fundamental strength.
    *   **Risk:** The high MDD across recent timeframes suggests the stock is high risk.
*   **Overall Recommendation:** Given the underperformance, mixed signals, and high risk, a cautious approach is warranted. Investors should carefully consider their risk tolerance and conduct further due diligence before investing in NOC.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.